SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SYNTHETECH - NZYM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scott H. Davis who wrote (279)5/26/1999 10:34:00 AM
From: Dan Gibbs  Read Replies (1) of 372
 
Although I have been a fan of NZYM for many years, I was very pleasantly surprised by the earnings announcement yesterday. The 15 cent quarter and 38 cent year certainly beat my most optimistic expectations. But in addition, margins are up and perhaps most significantly, the company started the new fiscal year with a $9 million backlog. Even if you take out the approximately $3 million contribution from the project that will end this summer, this is still the largest backlog the company has ever had. It looks like there is quite a bit of relatively high margin new business coming in. The long term growth prospects for NZYM appear to be very much on track.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News